Depression and Mortality in End-Stage Renal Disease

被引：65

作者：

Halen, Nisha Ver ^{[1
]}

Cukor, Daniel ^{[1
]}

Constantiner, Melissa ^{[1
]}

Kimmel, Paul L. ^{[2
]}

机构：

[1] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA

[2] George Washington Univ, Dept Med, Washington, DC 20037 USA

来源：

CURRENT PSYCHIATRY REPORTS | 2012年 / 14卷 / 01期

关键词：

Depression; End-stage renal disease; ESRD; Hemodialysis; Survival; Review; Renal disease; Mortality; QUALITY-OF-LIFE; CHRONIC KIDNEY-DISEASE; CHRONIC-HEMODIALYSIS PATIENTS; CHRONIC PERITONEAL-DIALYSIS; MAJOR DEPRESSION; SOCIAL SUPPORT; PSYCHOSOCIAL FACTORS; BEHAVIORAL COMPLIANCE; PRACTICE PATTERNS; UNITED-STATES;

D O I：

10.1007/s11920-011-0248-5

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

End-stage renal disease is growing in prevalence and incidence. With technical advancements, patients are living longer on hemodialysis. Depression is the most prevalent comorbid psychiatric condition, estimated at about 25% of end-stage renal disease samples. The identification and assessment of depression are confounded by the overlap between depression symptomatology and uremia. Several recent studies have employed time-varying models and identified a significant association between depression and mortality. Due to the high prevalence of depression and the potential impact on survival, well-constructed investigations are warranted.

引用

页码：36 / 44

页数：9

共 113 条

[1] The glucocorticoid receptor: Pivot of depression and of antidepressant treatment? [J].